Pramand develops implantable medical devices from novel, proprietary hydrogel materials that improve patient outcomes while lowering the cost of therapy. We self-fund our projects through preclinical development and work with financial partners for clinical development and commercialization.
Pramand’s portfolio of proprietary hydrogel technology positions us to be the leader in creating new hydrogel based medical devices to address unmet medical needs in a range of surgical interventions.
Our team has launched over ten medical device companies based on hydrogel technology. These companies have generated over $4B in value and exits and have helped over 5 million patients worldwide achieve better outcomes.
Copyright © 2023 Pramand LLC
These statements have not been evaluated by the Food and Drug Administration.
PRA-MKT-0006 Rev. A
Cover image by upklyak on Freepik